New tool aims to help IPF patients better manage their own care
NCT ID NCT07139925
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study is testing whether a questionnaire originally designed for COPD patients can be adapted to measure self-care in people with idiopathic pulmonary fibrosis (IPF). Researchers will enroll 156 adults with IPF to see if the tool accurately captures how well patients manage their condition. The goal is to give doctors and patients a simple way to track self-care and improve daily disease management.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could provide doctors and patients with a reliable way to measure self-care in IPF, potentially leading to better disease management and quality of life.
- What could go wrong
- This is an observational validation study, not a treatment trial. The tool may not prove accurate or useful in all IPF patients, and it does not directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IPF are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli
Roma, Roma, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a breath test predict lung scarring? new study seeks answers
- New inhaled drug for lung disease tested in healthy people first
- New hope for lung scarring: HSK44459 enters final trial phase
- Healthy volunteers to test experimental lung disease drug
- New drug for lung scarring takes first step in healthy volunteers
- Simple questionnaire could bring palliative care home for lung disease patients